LAX.SH
SAKAR HEALTHCARE LIMITED·PHARMACEUTICALS 66.37·Pharmaceuticals & Biotechnology Companies
Price
951.8
+5.19%52W Range
Market Cap
₹2,117.75 Cr
Traded: ₹11.83 Cr (0.56%) 0.0x
Free Float: ₹507.84 Cr (2.33% of FF traded)
Volume · 60D trend
1.28 L 0.0x
Delivery: % 0.0x
View Delivery Data
Returns
RS Score
Create a free account to unlock your edge
Scanners, market pulse, FII/DII data, and TradingView charts — free forever
Valuation
Business Strength
Growth (3Y CAGR)
Balance Sheet
Cash Position
Others
MTF Exposure Trend
60 sessions · funded amount, % of FF, daily delta
LAX.SH
Growth Trends
| Metric | 10Y | 5Y | 3Y | 1Y | TTM | Trend |
|---|---|---|---|---|---|---|
| Sales | -- | +22.0% | +24.0% | -- | +44.0% | Accelerating |
| ROE | -- | +8.0% | +8.0% | -- | -- | Stable |
| Return | -- | +36.0% | +47.0% | +121.0% | -- | Accelerating |
| Profit | -- | +23.0% | +34.0% | -- | +82.0% | Accelerating |
Quarterly Results
Mar 2023
Dec 2022
Sep 2022
Revenue & Margin Trends
Annual
Quarterly
Balance Sheet Health
Leverage
Efficiency
Cash Position
Detailed Financials
Jun 2026PDF ↗ | Mar 2026PDF ↗ | Dec 2025PDF ↗ | Sep 2025PDF ↗ | Jun 2025PDF ↗ | Mar 2025PDF ↗ | Dec 2024PDF ↗ | Sep 2024PDF ↗ | Jun 2024PDF ↗ | Mar 2024PDF ↗ | Dec 2023PDF ↗ | Sep 2023PDF ↗ | Jun 2023PDF ↗ | Mar 2023 | Dec 2022 | Sep 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 73 | 71 | 70 | 58 | 53 | 50 | 43 | 43 | 41 | 43 | 37 | 34 | 39 | 41 | 33 | 31 |
| Expenses | 52 | 45 | 52 | 46 | 40 | 35 | 32 | 31 | 30 | 32 | 28 | 25 | 30 | 33 | 25 | 22 |
| Operating Profit | 21 | 26 | 19 | 11 | 13 | 16 | 12 | 12 | 11 | 11 | 9 | 9 | 9 | 8 | 9 | 9 |
| Other Income | 2 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 2 | 2 | 2 | 1 |
| Interest | 2 | 2 | 2 | 2 | 2 | 4 | 1 | 2 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 1 |
| Depreciation | 7 | 6 | 6 | 6 | 6 | 5 | 5 | 5 | 5 | 5 | 4 | 4 | 5 | 4 | 4 | 4 |
| Profit Before Tax | 15 | 18 | 11 | 5 | 5 | 6 | 5 | 5 | 5 | 5 | 3 | 4 | 4 | 4 | 5 | 4 |
| Tax % | 29.0% | 39.0% | 6.0% | 15.0% | 13.0% | 8.0% | 17.0% | 6.0% | 49.0% | 35.0% | 31.0% | 13.0% | 28.0% | -1.0% | 13.0% | 56.2% |
| Net Profit | 10 | 11 | 10 | 5 | 5 | 6 | 5 | 5 | 2 | 3 | 2 | 4 | 3 | 4 | 4 | 2 |
| Exceptional Items | -- | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 |
| EPS (Rs) | 4.6 | 5.0 | 4.6 | 2.0 | 2.1 | 2.6 | 2.1 | 2.2 | 1.1 | 1.4 | 0.9 | 1.7 | 1.5 | 2.1 | 2.1 | 1.0 |
| Sales Growth (YoY) | 37.7% | 42.0% | 62.8% | 34.9% | 29.3% | 16.3% | 16.2% | 26.5% | 5.1% | 4.9% | 12.1% | 10.7% | -- | -- | -- | -- |
| Sales Growth (QoQ) | 2.8% | 1.4% | 20.7% | 9.4% | 6.0% | 16.3% | 0.0% | 4.9% | -4.7% | 16.2% | 8.8% | -12.8% | -4.9% | 24.2% | 7.5% | -- |
| OP Growth (YoY) | 61.5% | 62.5% | 58.3% | -8.3% | 18.2% | 45.5% | 33.3% | 33.3% | 22.2% | 37.5% | 0.0% | 4.8% | -- | -- | -- | -- |
| OP Growth (QoQ) | -19.2% | 36.8% | 72.7% | -15.4% | -18.8% | 33.3% | 0.0% | 9.1% | 0.0% | 22.2% | 0.0% | 0.0% | 12.5% | -11.1% | 4.8% | -- |
| Profit Growth (YoY) | -- | 91.0% | 124.0% | -5.0% | 94.0% | 85.0% | 121.0% | 32.0% | -15.0% | -21.0% | -48.0% | 88.0% | -1.0% | -56.0% | 3545.0% | -21.1% |
| EPS Growth (YoY) | 120.0% | 88.9% | 123.8% | -7.7% | 89.2% | 83.2% | 116.8% | 30.0% | -25.5% | -30.6% | -55.8% | 63.5% | -- | -- | -- | -- |
| EPS Growth (QoQ) | -6.7% | 7.4% | 126.0% | -2.9% | -19.9% | 27.2% | -6.8% | 99.1% | -22.4% | 50.5% | -44.1% | 14.1% | -27.7% | -4.2% | 106.7% | -- |
| OP Margin | 28.8% | 36.6% | 27.1% | 19.0% | 24.5% | 32.0% | 27.9% | 27.9% | 26.8% | 25.6% | 24.3% | 26.5% | 23.1% | 19.5% | 27.3% | 28.0% |
| Net Margin | 13.7% | 15.5% | 14.3% | 8.6% | 9.4% | 12.0% | 11.6% | 11.6% | 4.9% | 7.0% | 5.4% | 11.8% | 7.7% | 9.8% | 12.1% | 6.3% |
| Material Cost % | -- | 39.9% | 50.5% | 52.8% | 54.9% | 29.2% | 52.1% | 53.5% | 53.6% | 57.9% | 55.7% | 49.5% | 54.3% | 55.3% | 54.0% | 56.0% |
| Employee Cost % | -- | 18.2% | 14.1% | 14.5% | 14.3% | 31.6% | 11.3% | 12.8% | 13.1% | 12.1% | 12.1% | 13.8% | 13.8% | 13.1% | 14.0% | 11.0% |
| P/S | 7.79 | 7.31 | 5.10 | 5.40 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/E | 58.68 | 60.41 | 46.58 | 56.08 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/B | 6.54 | 5.68 | 3.89 | 3.63 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Annual Reports
7Credit Ratings
6Concalls
4Feb 2026
28 Feb 2026Nov 2025
30 Nov 2025Oct 2022
31 Oct 2022Dec 2018
31 Dec 2018